The Role of COX-2 Inhibition in Salt Sensitivity of Blood Pressure

Completed · Phase 4 · Has a placebo group

Conditions studied: Hypertension

In brief

The purpose of this study is to determine if the drug Celebrex changes the way the kidney gets rid of salt and maintains blood pressure.

Key facts

Study ID

NCT00624559

Run by

University of Delaware

People needed

12

Starts

2008-02-01

Expected to finish

2009-01-01

Last updated by the study team

2012-01-06

Who can join

Age: 22 and older, up to 50. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• healthy men and women

You may not qualify if…

• history of heart disease
• have had heart surgery
• high blood pressure
• diabetes
• cancer
• any other disease such as kidney or neurological diseases
• taking medications such as aspirin or medicines for your heart or blood pressure
• have asthma or are allergic to sulfa drugs
• body mass index greater than 30
• use tobacco
• pregnant
• women using oral contraceptives or hormone replacement therapy

Where it is running

• University of Delaware — Newark, Delaware, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.